Exclusive executive briefing reserved to IP Expert, Counsel, Manager and Strategist, Litigation specialist, Patent attorney, Heads/IP Director, Corporate-Legal Counsel, Private practice lawyer.
On the eve of the conference UP/UPC 2017 (http://www.unitarypatentsystem.eu/), Premier Cercle organises a unique gathering around an Executive Briefing dedicated to the Pharmaceutical and Lifesciences industries.
This event will take place at Seehaus (English Garden) in Munich on July 4, 2017 from 6 to 10 PM.
The theme of the executive briefing is the mid-term strategies to be adopted by pharmaceutical companies under the new patent regime. The upcoming launch of the Unified Patent Court and the opt-in/opt-out options introduced by the UPCA will shape the strategy of many corporations.
In order to discuss the medium term and long-term strategies within start-ups, SME’s and big corporations in the industry, we will invite seasoned patent practitioners to share their strategic analysis of the current situation and the actions to be taken in the sunrise period.
This exciting debate will be followed by a networking dinner. The delegates are high-ranking IP professionals and international and European associations’ representatives coming from all over Europe.
The venue has capacity constraints and only 50 participants will be accepted.
In today’s intensely competitive pharmaceutical and biotech industries, it is crucial to keep abreast of the latest developments to ensure your organisation implement the right strategies to protect its patent portfolio and maximize value creation opportunities. This highly informative, content-driven dinner, led by our world-class research, will showcase practical solutions to the challenges faced by life sciences, pharmaceutical and biotech companies, legal practitioners and other key stakeholders.
Join us to share your experience and professional expertise on this specific issues with European attorneys, in-house legal counsel and international associations in the field.
Confirmed speakers :
- Fiona Bor : Head of Intellectual Property /// Mereo BioPharma
European Intellectual Property Counsel of the Year 2017
- Dr. Jörg Thomaier : CEO, Intellectual Property Gmbh, Head of IP /// Bayer Group
- Stefan Drouin : Head of the European Patent Department /// UCB